The Society for Immunotherapy of Cancer’s (SITC) Fellowship Awards program was established through the Forward Fund to support the development of young investigators in the field to cultivate the next generation of cancer immunotherapy experts. Since 2014, SITC has committed more than $2 million in fellowship awards to deserving young investigators.
The Society for Immunotherapy of Cancer (SITC) is pleased to announce the recipients of three 2019 Fellowship Awards, which support the next generation of cancer immunotherapy and tumor immunology experts through dedicated funding of novel research.
The SITC Fellowship Awards program was established through the society’s Forward Fund, which has committed more than $2 million in Fellowship Award opportunities to deserving young investigators since 2014.
This year’s SITC Named Fellowship Awards were made possible through the generosity of Amgen, AstraZeneca Pharmaceuticals LP and Genentech, Inc.
The award recipients will be honored during a ceremony at the society’s 34th Annual Meeting on Saturday, Nov. 9, 2019, at the Gaylord National Hotel & Convention Center in National Harbor, Md.
Recipient: Lekha Mikkilineni, MD, National Cancer Institute
Co-sponsored by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) and SITC and made possible in part by an educational grant from EMD Serono.
Recipient: Shaheen Khan, PhD, University of Texas Southwestern Medical Center
Project Title: Investigating Host Immune Factors in Mediating Immune-Related Adverse EventsCo-sponsored by the Melanoma Research Alliance and SITC
Interested in supporting a SITC Fellowship? Contact SITC Development at firstname.lastname@example.org or +1 414-271-2456.Also, visit our Frequently Asked Questions page for more details about the SITC Fellowship Awards.
Looking to view past recipients of SITC Fellowship Awards? Click the links below:
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com